These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 17376042)

  • 21. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.
    Beymer C; Kowdley KV; Larson A; Edmonson P; Dellinger EP; Flum DR
    Arch Surg; 2003 Nov; 138(11):1240-4. PubMed ID: 14609874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery.
    Mottin CC; Moretto M; Padoin AV; Kupski C; Swarowsky AM; Glock L; Duval V; da Silva JB
    Obes Surg; 2005; 15(6):788-93. PubMed ID: 15978148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA; Kunde SS; Lazenby AJ; Clements RH
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery.
    Harnois F; Msika S; Sabaté JM; Mechler C; Jouet P; Barge J; Coffin B
    Obes Surg; 2006 Feb; 16(2):183-8. PubMed ID: 16469221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of bariatric surgery on the non-alcoholic liver steatosis. A histological evaluation].
    Ferrer Márquez M; Carvia Pousaillè C; Velasco Albendea J; Rico Morales Mdel M; Casado Martín M; Belda Lozano R; Ferrer Ayza M
    Cir Esp; 2009 Aug; 86(2):94-100. PubMed ID: 19560754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis.
    Mishra P; Nugent C; Afendy A; Bai C; Bhatia P; Afendy M; Fang Y; Elariny H; Goodman Z; Younossi ZM
    Liver Int; 2008 Sep; 28(8):1080-6. PubMed ID: 18647236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.
    Trak-Smayra V; Dargere D; Noun R; Albuquerque M; Yaghi C; Gannagé-Yared MH; Bedossa P; Paradis V
    Gut; 2009 Jun; 58(6):825-32. PubMed ID: 18403495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients.
    Cotrim HP; Freitas LA; Alves E; Almeida A; May DS; Caldwell S
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):969-72. PubMed ID: 19194305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.
    Keshishian A; Zahriya K; Willes EB
    Obes Surg; 2005; 15(10):1418-23. PubMed ID: 16354521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Obesity: risk factor for steatohepatitis and hepatic fibrosis].
    Poniachik J; Mancilla C; Contreras J; Csendes A; Smok G; Cavada G; Rojas J; Oksenberg D; Burdiles P; Maluenda F; Díaz JC
    Rev Med Chil; 2002 Jul; 130(7):731-6. PubMed ID: 12235896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery.
    De Ridder RJ; Schoon EJ; Smulders JF; van Hout GC; Stockbrügger RW; Koek GH
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():195-201. PubMed ID: 18081662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study.
    Caiazzo R; Lassailly G; Leteurtre E; Baud G; Verkindt H; Raverdy V; Buob D; Pigeyre M; Mathurin P; Pattou F
    Ann Surg; 2014 Nov; 260(5):893-8; discussion 898-9. PubMed ID: 25379859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery.
    Dolce CJ; Russo M; Keller JE; Buckingham J; Norton HJ; Heniford BT; Gersin KS; Kuwada TS
    Surg Obes Relat Dis; 2009; 5(3):323-8. PubMed ID: 19356994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?
    Crespo J; Fernández-Gil P; Hernández-Guerra M; Cayón A; Mayorga M; Domínguez-Diez A; Fernández-Escalante JC; Pons-Romero F
    Obes Surg; 2001 Jun; 11(3):254-7. PubMed ID: 11433896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis.
    Bechmann LP; Gieseler RK; Sowa JP; Kahraman A; Erhard J; Wedemeyer I; Emons B; Jochum C; Feldkamp T; Gerken G; Canbay A
    Liver Int; 2010 Jul; 30(6):850-9. PubMed ID: 20408954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.